Overview

Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
To determine how safe and effective giving Thymoglobulin before transplantation to patients who are going to be receiving kidney transplants.
Phase:
Phase 4
Details
Lead Sponsor:
University of Cincinnati
Collaborator:
Genzyme, a Sanofi Company
Treatments:
Antilymphocyte Serum
Tacrolimus
Thymoglobulin